We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Exosomes Infected with Prions Diagnostic for vCJD

By LabMedica International staff writers
Posted on 24 Oct 2012
Newly available genetic sequencing enables scientists to discover cells infected with prions, the infectious agent responsible Creutzfeldt-Jakob disease (vCJD) and Bovine Spongiform Encephalopathy (BSE), commonly known as Mad Cow Disease.

Exosomes are shed into blood, urine, and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. More...
If the exosomes are infected with prions, they also carry a specific signature of microRNA's (miRNAs). In this study, scientists focused their genetic testing on the exosomes. Circulating exosomes released during prion infection have a distinct miRNA signature that can be utilized for diagnosis and understanding pathogenic mechanisms in prion disease. Associate Professor Andrew Hill - from the Department of Biochemistry and Molecular Biology at the Bio21 Institute (Melbourne, VIC, Australia), said that these particles travel in the bloodstream, making a diagnostic blood test a possibility.

Mad Cow disease was linked to the deaths of nearly 200 people in Great Britain who consumed meat from infected animals in the late 1980s. Since the year 2000, the Australian Red Cross Blood Service has not accepted blood from anybody who lived in the UK for more than six months between 1980 and 1996, or who received a blood transfusion in the UK after 1980.

Commenting on the possibility in the future of a blood test for Mad Cow Disease, Prof. Hill said, "This might provide a way to screen people who have spent time in the UK, who currently face restrictions on their ability to donate blood. With a simple blood test nurses could deem a prospective donor's blood as healthy, with the potential to significantly boost critical blood stocks."

The research is published in the September 2012 issue of Oxford University Press Nucleic Acids Research. Lead author Dr. Shayne Bellingham said the breakthrough might also help detect other human neurodegenerative diseases, such as Alzheimer's and Parkinson's.

The study was undertaken at the University of Melbourne (VIC, Australia), with assistance from the Mental Health Research Institute of Victoria, the National Health and Medical Research Council and the Australian Research Council.

Related Links:
Bio21 Institute
University of Melbourne


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Multi-Chamber Washer-Disinfector
WD 390
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.